Literature DB >> 12798607

Theoretic coverage of heptavalent pneumococcal conjugate vaccine in the prevention of community-acquired pneumonia in children in Italy.

Susanna Esposito1, Dace V Madore, Stefania Gironi, Samantha Bosis, Silvia Tosi, Ciro Bianchi, Carolyn Cimino, Nicola Principi.   

Abstract

In order to evaluate the theoretic coverage of the heptavalent conjugate vaccine against community-acquired pneumonia (CAP) during the first years of life, the anti-capsular IgG antibodies to the nine more common pneumococcal serotypes (1, 4, 5, 6B, 9V, 14, 18C, 19F, 23F) were quantitated in 196 affected children aged 2-5 years by means of enzyme-linked immunosorbent assays of acute and convalescent serum samples. Acute Streptococcus pneumoniae infection associated with the nine tested serotypes was diagnosed in 57 children (29.1%). Serological data indicated that 16.8% of CAPs were caused by serotypes included in the heptavalent conjugate vaccine. This study confirms the significant role of S. pneumoniae in pediatric CAP, and highlights the importance of pneumococcal conjugate vaccines in preventing it during the first years of life.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12798607     DOI: 10.1016/s0264-410x(03)00110-5

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  1 in total

1.  Impact on respiratory tract infections of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months of age.

Authors:  Susanna Esposito; Alessandro Lizioli; Annalisa Lastrico; Enrica Begliatti; Alessandro Rognoni; Claudia Tagliabue; Laura Cesati; Vittorio Carreri; Nicola Principi
Journal:  Respir Res       Date:  2007-02-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.